Pharma Stocks
-
option deal boosts global Alzheimer’s ambition
Shanghai Fosun Pharmaceutical has agreed to pay up to USD 240 million more for global rights to AriBio’s experimental Alzheimer’s…
Read More » -
buyback, earnings momentum and fresh highs draw investor
Aurobindo Pharma Ltd has completed a sizeable share buyback and continues to post growing profits, while the stock trades near…
Read More » -
Bayer News On Camelina Alliance And Cardiac Imaging Progress At A Discount
Bayer (XTRA:BAYN) announced a major alliance with bp to commercialize camelina as a renewable fuel feedstock. The company reported positive…
Read More » -
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
Traws Pharma, Inc. Private financing of up to $60M offering of common stock (with $10M upfront) and milestone-based warrants expected…
Read More » -
Rajesh Palviya of Axis Sec suggests Ajanta Pharma, Tata Communications, NMDC shares to buy today – 15 May
Stock market today: Benchmark equity indices Sensex and Nifty 50 opened higher on Friday, 15 May, supported by gains in…
Read More » -
Vertex Pharmaceuticals (VRTX) Is Up 6.0% After New ESOP Shelf, CASGEVY Deal And Guidance Reaffirmation
In early May 2026, Vertex Pharmaceuticals filed a new US$2.87 billion shelf registration for 6,400,000 common shares tied to its employee…
Read More » -
Doximity Flags Pharma Ad Market Weakness – Doximity (NYSE:DOCS)
Doximity, an operator of an online networking service for medical professionals, reported fourth-quarter revenue of $145.4 million, up 5% year…
Read More » -
Latest financials and China pharma exposure
Sinopharm Group Co Ltd, China’s leading pharmaceutical distributor, reported trailing twelve-month revenue of CNY 332.22 billion as of recent data,…
Read More » -
Why Milestone Pharmaceuticals Stock Wilted on Wednesday
Not many investors were willing to walk a mile with Milestone Pharmaceuticals (MIST 9.47%) on Hump Day. Shares of the…
Read More » -
Morgan Stanley Increases Price Goal on Alnylam Pharmaceuticals, Inc. (ALNY)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 8 Most Promising Biotech Stocks to Buy Now. On May 1, Morgan…
Read More »